Inspire Medical Systems Inc (INSP)
202.48
-4.62
(-2.23%)
USD |
NYSE |
Sep 27, 16:00
202.35
-0.13
(-0.06%)
Pre-Market: 20:00
Inspire Medical Systems Research and Development Expense (Annual): 116.54M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 116.54M |
| December 31, 2022 | 68.64M |
| December 31, 2021 | 37.35M |
| December 31, 2020 | 26.09M |
| December 31, 2019 | 12.84M |
| Date | Value |
|---|---|
| December 31, 2018 | 7.388M |
| December 31, 2017 | 6.194M |
| December 31, 2016 | 7.091M |
| December 31, 2015 | 7.079M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
12.84M
Minimum
2019
116.54M
Maximum
2023
52.29M
Average
37.35M
Median
2021
Research and Development Expense (Annual) Benchmarks
| Nevro Corp | 54.42M |
| Axonics Inc | 34.89M |
| Inari Medical Inc | 87.53M |
| Electromed Inc | 0.656M |
| Myomo Inc | 2.636M |